Global Drug Screening Market to Witness Rapid Growth in Coming Years – Projected to Reach Worth USD 14.14 Billion in 2027

Published | 23 June 2021

A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global drug screening market was worth USD 4.47 Billion in the year 2020 and anticipated to grow at a CAGR of 18.6% during 2021-2027 (forecast period). Concerns about growing alcohol and drug abuse cases around the world have contributed to the market's growth. The drug screening market has also grown in popularity due to increased demand from institutions such as workplaces, schools, and the sports industry. Drug testing is performed to screen athletes for drug misuse. It is also used for screening employers before hiring or random inspection. Rising public awareness about the dangers of drug usage, as well as government funding for drug screening programs, have all contributed to the market's growth.

The drug screening market has also grown as a result of new and diverse drug screening applications, as well as creative product developments. This has resulted in better services for customers, such as faster and more accurate results. However, the ongoing controversy over invasion of privacy as a result of drug screening has reduced market demand. The banning of alcohol consumption in many Islamic countries has also affected the geographical expansion of the drug and screening market across the globe. The drawback of the breathalyzer test's inefficiency has also resulted in a reduction in drug and screening market growth.

Innovative Products Expanding Market Opportunities

The drug screening industry is experiencing a surge in demand as a result of the availability of novel goods, which has enhanced consumer satisfaction. For example, the innovative organ-on-a-chip system has revolutionized the drug screening process and is also aiding in clinical studies. It is a microfluidic chip that can stimulate any organ like the liver, gut, and even tumors on a chip. Fingerprint-based testing has also emerged as a novel breakthrough in this market and has gained prominence throughout the pandemic. Fingerprint-based testing is highly preferred as they are non-invasive, hygienic, facilitates social distancing, and requires no specific preparation for sample collection. The growing opportunities offered by such innovations are likely to replace urine, hair, and blood samples in the future.

Concern Over Substance Abuse Creating Driving Demand

The rate of increased drug and alcohol consumption all over the globe is an alarming issue. According to the American Academy of Child & Adolescent Psychiatry, alcohol and drug abuse accounts for approximately 50% all deaths in the 15–24 age group. Among teenagers, the figures are alarming. Every day about 28 people in the U.S. die due to drunk-driving-related accidents, i.e., 1 person in every 52 minutes. Such alarming numbers have resulted in a greater awareness of the dangers of drug and alcohol use. This has created a demand for the drug screening market across the globe. Additionally, many governments are providing funds for testing programs and passing stringent laws to reduce these alarming numbers.

Urine Sample Segment Dominates the Market

The global drug screening market, based on sample type, is categorized into oral fluid,hair, breath, urine, and other samples. The urine sample segment held the largest market share in 2020. The driving factor for the growth of this segment is lost cost procedure and reliability of results. They are used in drug screening for the presence of cocaine, marijuana, and opiates. They are demanded in many workplace organizations to conduct screening procedures before hiring new employees. As a result of this demand, this segment has a sizable market share in the worldwide drug screening market.

Impact of COVID-19

The outbreak of the coronavirus pandemic has had a negative impact on the growth of the drug screening market. Many sectors' industrial activity has been significantly hampered as a result of the nationwide lockdown and temporary closures. The closure of manufacturing, processing, and commercial organizations has also impacted the drug screening market's product availability. Travel bans and trade restrictions have widened the gap between supply and demand for the market. Furthermore, the focus of the healthcare sector, majorly on COVID-related cases, has also reduced the demand for the drug screening market. However, the rapid testing devices segment of this market has found its massive application in the diagnosis of coronavirus.

North America Contributing Largest Market Share

Based on region, the Drug Screening Market is categorized into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. North America dominated the global market with the largest share in 2020. Rising drug abuse cases in this region have prompted the government to release funds for spreading awareness related to drug testing programs, which in turn is driving the growth of the marker. For instance, the Drug Testing Center of America has focused its efforts on providing cost-effective drug testing services to its population. During the projected period, however, the Asia-Pacific region is predicted to contribute the most to the worldwide drug screening market. The alarming rise in drug and alcohol use in this region has created market demand. Around 147,660 cases of drug abuse were reported in medical centers from Taiwan alone. As per the China Real-Time report, about 51% of teens are involved in alcohol consumption.

Competitive Landscape

The Drug Screening Market is highly competitive and fragmented with international and regional players. The key players dominating the market are LabCorp, Quest Diagnostics, Abbott Rapid Diagnostics, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux SA, Synergy Health plc., CareHealth America Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players. Many firms are collaborating with government and agencies to raise awareness about substance abuse. This has improved the consumer reach of this market and contributed to the benefit of society.

Don’t miss the business opportunity of the global drug screening market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and theglobal drug screening market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global drug screening market ­ along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

Blue Weave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.